OCI Acquires 11% Stake in Bukwang Pharm for 146.1 Billion KRW, Becomes Largest Shareholder
[Asia Economy Reporter Kwon Jae-hee] OCI announced on the 22nd that it will acquire 7,730,334 shares held by Chairman Kim Dong-yeon, the largest shareholder of Bukwang Pharm, and 9 other related parties for 146.1 billion KRW.
This corresponds to 6.12% of OCI's equity capital.
With this acquisition, OCI's shares in Bukwang Pharm will increase to 7,747,934 shares, raising its stake to 10.90%.
OCI stated, "The acquisition was made to expand our entry into the bio business."
Hot Picks Today
"This Is the First Time in 38 Years"... Real-Time Situation Unfolds at U.S. Airports
- "Monthly Salary Exceeds 10 Million Won"... The Top Job in Japan Even Doctors Envy
- Samsung Electronics Target Price Cut from 550,000 Won to 370,000 Won... Why Was It Lowered by 33% [Click e-Stock]
- 30-Year Yield Hits 5.21% Despite Fed Rate Hold, Highest in 19 Years
- "Bring a Friend and Get 1.18 Million Won"... Dubai Starts Offering Cash Incentives Amid Tourism Slump
The scheduled date for the stock acquisition is March 8.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
